Abstract
The emergence of antibiotic-resistant bacteria, dubbed superbugs, together with relative stagnation in developing efficient antibiotics has led to enormous health and economic problems, necessitating the need for discovering and developing novel antimicrobial agents. In this respect, animal venoms represent a rich repertoire of pharmacologically active components. As a major component in the venom of European honeybee Apis mellifera, melittin has a great potential in medical applications. In this mini-review, we summarize a multitude of studies on anti-bacterial effects of melittin against planktonic and biofilm-embedded bacteria. Several investigations regarding synergistic effects between melittin and antibiotics were also described. On the whole, the properties of melittin can open up new horizons in a range of biomedical areas, from agriculture to veterinary and clinical microbiology.
Similar content being viewed by others
References
Al-Ani I, Zimmermann S, Reichling J, Wink M (2015) Pharmacological synergism of bee venom and melittin with antibiotics and plant secondary metabolites against multi-drug resistant microbial pathogens. Phytomedicine 22(2):245–255. https://doi.org/10.1016/j.phymed.2014.11.019
Almeida JR, Palacios ALV, Patiño RSP, Mendes B, Teixeira CAS, Gomes P, da Silva SL (2018) Harnessing snake venom phospholipases A2 to novel approaches for overcoming antibiotic resistance. Drug Dev Res. https://doi.org/10.1002/ddr.21456
An HJ, Kim JY, Kim WH, Gwon MG, Gu HM, Jeon MJ, Han SM, Pak SC, Lee CK, Park IS, Park KK (2018) Therapeutic effects of bee venom and its major component, melittin, on atopic dermatitis in vivo and in vitro. Br J Pharmacol 175(23):4310–4324. https://doi.org/10.1111/bph.14487
Anderson D, Terwilliger TC, Wickner W, Eisenberg D (1980) Melittin forms crystals which are suitable for high resolution X-ray structural analysis and which reveal a molecular 2-fold axis of symmetry. J Biol Chem 255(6):2578–2582
Andreotti N, Jouirou B, Mouhat S, Mouhat L, Sabatier J (2010) Therapeutic value of peptides from animal venoms. In: Mandler L, Liu HW (eds) Comprehensive natural products II. Elsevier, Oxford, pp 287–303
Bardbari AM, Arabestani MR, Karami M, Keramat F, Aghazadeh H, Alikhani MY, Bagheri KP (2018) Highly synergistic activity of melittin with imipenem and colistin in biofilm inhibition against multidrug-resistant strong biofilm producer strains of Acinetobacter baumannii. Eur J Clin Microbiol Infect Dis 37(3):443–454. https://doi.org/10.1007/s10096-018-3189-7
Batoni G, Maisetta G, Esin S (2016) Antimicrobial peptides and their interaction with biofilms of medically relevant bacteria. Biochim Biophys Acta 1858(5):1044–1060. https://doi.org/10.1016/j.bbamem.2015.10.013
Bazzo R, Tappin MJ, Pastore A, Harvey TS, Carver JA, Campbell ID (1988) The structure of melittin. A 1H-NMR study in methanol. Eur J Biochem 173(1):139–146. https://doi.org/10.1111/j.1432-1033.1988.tb13977.x
Benton AW, Morse RA, Kosikowski FV (1963) Bioassay and standardization of venom of the honey bee. Nature 198:295–296. https://doi.org/10.1038/198295b0
Béven L, Wróblewski H (1997) Effect of natural amphipathic peptides on viability, membrane potential, cell shape and motility of mollicutes. Res Microbiol 148(2):163–175. https://doi.org/10.1016/S0923-2508(97)87647-4
Björn C, Noppa L, Näslund Salomonsson E, Johansson AL, Nilsson E, Mahlapuu M, Håkansson J (2015) Efficacy and safety profile of the novel antimicrobial peptide PXL150 in a mouse model of infected burn wounds. Int J Antimicrob Agents 45(5):519–524. https://doi.org/10.1016/j.ijantimicag.2014.12.015
Blondelle SE, Houghten RA (1991) Hemolytic and antimicrobial activities of the twenty-four individual omission analogues of melittin. Biochemistry 30(19):4671–4678. https://doi.org/10.1021/bi00233a006
Boman HG, Wade D, Boman IA, Wåhlin B, Merrifield RB (1989) Antibacterial and antimalarial properties of peptides that are cecropin-melittin hybrids. FEBS Lett 259(1):103–106. https://doi.org/10.1016/0014-5793(89)81505-4
Bucki R, Pastore JJ, Randhawa P, Vegners R, Weiner DJ, Janmey PA (2004) Antibacterial activities of rhodamine B-conjugated gelsolin-derived peptides compared to those of the antimicrobial peptides cathelicidin LL37, magainin II, and melittin. Antimicrob Agents Chemother 48(5):1526–1533. https://doi.org/10.1128/AAC.48.5.1526-1533.2004
Cerovský V, Hovorka O, Cvacka J, Voburka Z, Bednárová L, Borovicková L, Slaninová J, Fucík V (2008) Melectin: a novel antimicrobial peptide from the venom of the cleptoparasitic bee Melecta albifrons. Chembiochem 9(17):2815–2821. https://doi.org/10.1002/cbic.200800476
Choi JH, Jang AY, Lin S, Lim S, Kim D, Park K, Han SM, Yeo JH, Seo HS (2015) Melittin, a honeybee venom-derived antimicrobial peptide, may target methicillin-resistant Staphylococcus aureus. Mol Med Rep 12(5):6483–6490. https://doi.org/10.3892/mmr.2015.4275
Deslouches B, Steckbeck JD, Craigo JK, Doi Y, Burns JL, Montelaro RC (2015) Engineered cationic antimicrobial peptides to overcome multidrug resistance by ESKAPE pathogens. Antimicrob Agents Chemother 59(2):1329–1333. https://doi.org/10.1128/AAC.03937-14
Dorman LC, Markley LD (1971) Solid phase synthesis and antibacterial activity of N-terminal sequences of melittin. J Med Chem 14(1):5–9. https://doi.org/10.1021/jm00283a003
Dosler S, Gerceker AA (2012) In vitro activities of antimicrobial cationic peptides; melittin and nisin, alone or in combination with antibiotics against Gram-positive bacteria. J Chemother 24(3):137–143. https://doi.org/10.1179/1973947812Y.0000000007
Dosler S, Karaaslan E, Alev Gerceker A (2016) Antibacterial and anti-biofilm activities of melittin and colistin, alone and in combination with antibiotics against gram-negative bacteria. J Chemother 28(2):95–103. https://doi.org/10.1179/1973947815Y.0000000004
Ebbensgaard A, Mordhorst H, Overgaard MT, Nielsen CG, Aarestrup FM, Hansen EB (2015) Comparative evaluation of the antimicrobial activity of different antimicrobial peptides against a range of pathogenic bacteria. PLoS One 10(12):e0144611. https://doi.org/10.1371/journal.pone.0144611
Fennell JF, Shipman WH, Cole LJ (1967) Antibacterial action of a bee venom fraction (melittin) against a penicillin-resistant Staphylococcus and other microorganisms. USNRDL-TR-67-101. Res Dev Tech Rep 5:1–13
Gajski G, Garaj-Vrhovac V (2013) Melittin: a lytic peptide with anticancer properties. Environ Toxicol Pharmacol 36(2):697–705. https://doi.org/10.1016/j.etap.2013.06.009
George S, Kishen A, Song KP (2005) The role of environmental changes on monospecies biofilm formation on root canal wall by Enterococcus faecalis. J Endod 31(12):867–872. https://doi.org/10.1097/01.don.0000164855.98346.fc
Giacometti A, Cirioni O, Kamysz W, D'Amato G, Silvestri C, Del Prete MS, Lukasiak J, Scalise G (2003) Comparative activities of cecropin A, melittin, and cecropin A-melittin peptide CA(1-7)M(2-9)NH2 against multidrug-resistant nosocomial isolates of Acinetobacter baumannii. Peptides 24(9):1315–1318. https://doi.org/10.1016/j.peptides.2003.08.003
González-Rodríguez MÁ, Silva-Rojas HV, Mascorro-Gallardo JO (2005) In vitro assay of the antimicrobial peptide melittin against different phytopathogenic bacteria (article in Spanish). Rev Mex Fitopatol 23(2):176–182
Gopal R, Lee JH, Kim YG, Kim MS, Seo CH, Park Y (2013) Anti-microbial, anti-biofilm activities and cell selectivity of the NRC-16 peptide derived from witch flounder, Glyptocephalus cynoglossus. Mar Drugs 11(6):1836–1852. https://doi.org/10.3390/md11061836
Haagensen JA, Verotta D, Huang L, Spormann A, Yang K (2015) New in vitro model to study the effect of human simulated antibiotic concentrations on bacterial biofilms. Antimicrob Agents Chemother 59(7):4074–4081. https://doi.org/10.1128/AAC.05037-14
Habermann E (1972) Bee and wasp venoms. Science 177(4046):314–322. https://doi.org/10.1126/science.177.4046.314
Hale JD, Hancock RE (2007) Alternative mechanisms of action of cationic antimicrobial peptides on bacteria. Expert Rev Anti-Infect Ther 5(6):951–959. https://doi.org/10.1586/14787210.5.6.951
Han S, Yeo J, Baek H, Lin SM, Meyer S, Molan P (2009) Postantibiotic effect of purified melittin from honeybee (Apis mellifera) venom against Escherichia coli and Staphylococcus aureus. J Asian Nat Prod Res 11(9):796–804. https://doi.org/10.1080/10286020903164277
Hider RC (1988) Honeybee venom: a rich source of pharmacologically active peptides. Endeavour 12(2):60–65. https://doi.org/10.1016/0160-9327(88)90082-8
Høiby N, Bjarnsholt T, Givskov M, Molin S, Ciofu O (2010) Antibiotic resistance of bacterial biofilms. Int J Antimicrob Agents 35(4):322–332. https://doi.org/10.1016/j.ijantimicag.2009.12.011
Hossen S, Gan SH, Khalil I (2017) Melittin, a potential natural toxin of crude bee venom: probable future arsenal in the treatment of diabetes mellitus. J Chem 2017:1–7. https://doi.org/10.1155/2017/4035626
Kawakami H, Goto SG, Murata K, Matsuda H, Shigeri Y, Imura T, Inagaki H, Shinada T (2017) Isolation of biologically active peptides from the venom of Japanese carpenter bee, Xylocopa appendiculata. J Venom Anim Toxins Incl Trop Dis 23:29. https://doi.org/10.1186/s40409-017-0119-6
Khozani RS, Shahbazzadeh D, Harzandi N, Feizabadi MM, Bagheri KP (2018) Kinetics study of antimicrobial peptide, melittin, in simultaneous biofilm degradation and eradication of potent biofilm producing MDR Pseudomonas aeruginosa isolates. Int J Pept Res Ther 25:329–338. https://doi.org/10.1007/s10989-018-9675-z
Kim IH, Lee DG, Le SH, Ha JM, Ha BJ, Kim SK, Lee JH (2007) Antibacterial activity of Ulva lactuta against methicillin-resistant Staphylococcus aureus (MRSA). Biotechnol Bioproc Engg 12:579–582. https://doi.org/10.1007/BF02931358
King GF (2011) Venoms as a platform for human drugs: translating toxins into therapeutics. Expert Opin Biol Ther 11(11):1469–1484. https://doi.org/10.1517/14712598.2011.621940
Lam YH, Wassall SR, Morton CJ, Smith R, Separovic F (2001) Solid-state NMR structure determination of melittin in a lipid environment. Biophys J 81(5):2752–2761. https://doi.org/10.1016/S0006-3495(01)75918-8
Lazarev VN, Parfenova TM, Gularyan SK, Misyurina OY, Akopian TA, Govorun VM (2002) Induced expression of melittin, an antimicrobial peptide, inhibits infection by Chlamydia trachomatis and Mycoplasma hominis in a HeLa cell line. Int J Antimicrob Agents 19(2):133–137. https://doi.org/10.1016/S0924-8579(01)00479-4
Lazarev VN, Stipkovits L, Biro J, Miklodi D, Shkarupeta MM, Titova GA, Akopian TA, Govorun VM (2004) Induced expression of the antimicrobial peptide melittin inhibits experimental infection by Mycoplasma gallisepticum in chickens. Microbes Infect 6(6):536–541. https://doi.org/10.1016/j.micinf.2004.02.006
Lazarev VN, Shkarupeta MM, Kostryukova ES, Levitskii SA, Titova GA, Akopian TA, Govorun VM (2007) Recombinant plasmid constructs expressing gene for antimicrobial peptide melittin for the therapy of Mycoplasma and Chlamydia infections. Bull Exp Biol Med 144(3):452–456. https://doi.org/10.1007/s10517-007-0350-1
Leandro LF, Mendes CA, Casemiro LA, Vinholis AH, Cunha WR, de Almeida R, Martins CH (2015) Antimicrobial activity of apitoxin, melittin and phospholipase A2 of honey bee (Apis mellifera) venom against oral pathogens. An Acad Bras Cienc 87(1):147–155. https://doi.org/10.1590/0001-3765201520130511
Lee G, Bae H (2016) Anti-inflammatory applications of melittin, a major component of bee venom: detailed mechanism of action and adverse effects. Molecules 21(5):616. https://doi.org/10.3390/molecules21050616
Lee MT, Sun TL, Hung WC, Huang HW (2013) Process of inducing pores in membranes by melittin. Proc Natl Acad Sci U S A 110(35):14243–14248. https://doi.org/10.1073/pnas.1307010110
Lee WR, Kim KH, An HJ, Kim JY, Chang YC, Chung H, Park YY, Lee ML, Park KK (2014) The protective effects of melittin on Propionibacterium acnes-induced inflammatory responses in vitro and in vivo. J Invest Dermatol 134(7):1922–1930. https://doi.org/10.1038/jid.2014.75
Lewis RJ, Garcia ML (2003) Therapeutic potential of venom peptides. Nat Rev Drug Discov 2(10):790–802. https://doi.org/10.1038/nrd1197
Lubke LL, Garon CF (1997) The antimicrobial agent melittin exhibits powerful in vitro inhibitory effects on the Lyme disease spirochete. Clin Infect Dis 25(Suppl 1):S48–S51. https://doi.org/10.1086/516165
Macià MD, Rojo-Molinero E, Oliver A (2014) Antimicrobial susceptibility testing in biofilm-growing bacteria. Clin Microbiol Infect 20(10):981–990. https://doi.org/10.1111/1469-0691.12651
Matsuzaki K, Yoneyama S, Miyajima K (1997) Pore formation and translocation of melittin. Biophys J 73(2):831–838. https://doi.org/10.1016/S0006-3495(97)78115-3
Memariani H, Shahbazzadeh D, Sabatier JM, Memariani M, Karbalaeimahdi A, Bagheri KP (2016) Mechanism of action and in vitro activity of short hybrid antimicrobial peptide PV3 against Pseudomonas aeruginosa. Biochem Biophys Res Commun 479(1):103–108. https://doi.org/10.1016/j.bbrc.2016.09.045
Memariani H, Shahbazzadeh D, Ranjbar R, Behdani M, Memariani M, Pooshang Bagheri K (2017) Design and characterization of short hybrid antimicrobial peptides from pEM-2, mastoparan-VT1, and mastoparan-B. Chem Biol Drug Des 89(3):327–338. https://doi.org/10.1111/cbdd.12864
Memariani H, Shahbazzadeh D, Sabatier JM, Pooshang Bagheri K (2018a) Membrane-active peptide PV3 efficiently eradicates multidrug-resistant Pseudomonas aeruginosa in a mouse model of burn infection. APMIS 126(2):114–122. https://doi.org/10.1111/apm.12791
Memariani H, Memariani M, Pourmand MR (2018b) Venom-derived peptide Mastoparan-1 eradicates planktonic and biofilm-embedded methicillin-resistant Staphylococcus aureus isolates. Microb Pathog 119:72–80. https://doi.org/10.1016/j.micpath.2018.04.008
Moerman L, Bosteels S, Noppe W, Willems J, Clynen E, Schoofs L, Thevissen K, Tytgat J, Van Eldere J, Van Der Walt J, Verdonck F (2002) Antibacterial and antifungal properties of alpha-helical, cationic peptides in the venom of scorpions from southern Africa. Eur J Biochem 269(19):4799–4810. https://doi.org/10.1046/j.1432-1033.2002.03177.x
Mohamed MF, Brezden A, Mohammad H, Chmielewski J, Seleem MN (2017) Targeting biofilms and persisters of ESKAPE pathogens with P14KanS, a kanamycin peptide conjugate. Biochim Biophys Acta Gen Subj 1861(4):848–859. https://doi.org/10.1016/j.bbagen.2017.01.029
Monincová L, Veverka V, Slaninová J, Buděšínský M, Fučík V, Bednárová L, Straka J, Ceřovský V (2014) Structure-activity study of macropin, a novel antimicrobial peptide from the venom of solitary bee Macropis fulvipes (Hymenoptera: Melittidae). J Pept Sci 20(6):375–384. https://doi.org/10.1002/psc.2625
Nešuta O, Hexnerová R, Buděšínský M, Slaninová J, Bednárová L, Hadravová R, Straka J, Veverka V, Čeřovský V (2016) Antimicrobial peptide from the wild bee Hylaeus signatus venom and its analogues: structure-activity study and synergistic effect with antibiotics. J Nat Prod 79(4):1073–1083. https://doi.org/10.1021/acs.jnatprod.5b01129
Neumann W, Habermann E, Amend G (1952) Zur papierelektrophoretischen fraktionierung tierischer gifte. Naturwissenschaften 39(12):286–287. https://doi.org/10.1007/BF00591257
O'Neill J (2016) Tackling drug-resistant infections globally: Final report and recommendations. Wellcome Trust and HM Govt. http://amr-review.org/sites/default/files/160525_Final%20paper_with%20cover.pdf. Accessed 10 Oct 2018
Oren Z, Shai Y (1996) A class of highly potent antibacterial peptides derived from pardaxin, a pore-forming peptide isolated from Moses sole fish Pardachirus marmoratus. Eur J Biochem 237(1):303–310. https://doi.org/10.1111/j.1432-1033.1996.0303n.x
Oršolić N (2012) Bee venom in cancer therapy. Cancer Metastasis Rev 31(1–2):173–194. https://doi.org/10.1007/s10555-011-9339-3
Ortel S, Markwardt F (1955) Studies on the antibacterial properties of bee venom. [article in German]. Pharmazie 10(12):743–746
Overhage J, Campisano A, Bains M, Torfs EC, Rehm BH, Hancock RE (2008) Human host defense peptide LL-37 prevents bacterial biofilm formation. Infect Immun 76(9):4176–4182. https://doi.org/10.1128/IAI.00318-08
Pandey BK, Ahmad A, Asthana N, Azmi S, Srivastava RM, Srivastava S, Verma R, Vishwakarma AL, Ghosh JK (2010) Cell-selective lysis by novel analogues of melittin against human red blood cells and Escherichia coli. Biochemistry 49(36):7920–7929. https://doi.org/10.1021/bi100729m
Park SC, Kim JY, Shin SO, Jeong CY, Kim MH, Shin SY, Cheong GW, Park Y, Hahm KS (2006) Investigation of toroidal pore and oligomerization by melittin using transmission electron microscopy. Biochem Biophys Res Commun 343(1):222–228. https://doi.org/10.1016/j.bbrc.2006.02.090
Pashaei F, Bevalian P, Akbari R, Pooshang Bagheri K (2019) Single dose eradication of extensively drug resistant Acinetobacter spp. in a mouse model of burn infection by melittin antimicrobial peptide. Microb Pathog 127:60–69. https://doi.org/10.1016/j.micpath.2018.11.055
Paull BR, Yunginger JW, Gleich GJ (1977) Melittin: an allergen of honeybee venom. J Allergy Clin Immunol 59(4):334–338
Pennington MW, Czerwinski A, Norton RS (2018) Peptide therapeutics from venom: current status and potential. Bioorg Med Chem 26(10):2738–2758. https://doi.org/10.1016/j.bmc.2017.09.029
Picoli T, Peter CM, Zani JL, Waller SB, Lopes MG, Boesche KN, Vargas GDÁ, Hübner SO, Fischer G (2017) Melittin and its potential in the destruction and inhibition of the biofilm formation by Staphylococcus aureus, Escherichia coli and Pseudomonas aeruginosa isolated from bovine milk. Microb Pathog 112:57–62. https://doi.org/10.1016/j.micpath.2017.09.046
Piers KL, Brown MH, Hancock RE (1994) Improvement of outer membrane-permeabilizing and lipopolysaccharide-binding activities of an antimicrobial cationic peptide by C-terminal modification. Antimicrob Agents Chemother 38(10):2311–2316. https://doi.org/10.1128/AAC.38.10.2311
Rady I, Siddiqui IA, Rady M, Mukhtar H (2017) Melittin, a major peptide component of bee venom, and its conjugates in cancer therapy. Cancer Lett 402:16–31. https://doi.org/10.1016/j.canlet.2017.05.010
Raghuraman H, Chattopadhyay A (2007) Melittin: a membrane-active peptide with diverse functions. Biosci Rep 27(4–5):189–223. https://doi.org/10.1007/s10540-006-9030-z
Rajabnejad SH, Mokhtarzadeh A, Abnous K, Taghdisi SM, Ramezani M, Razavi BM (2018) Targeted delivery of melittin to cancer cells by AS1411 anti-nucleolin aptamer. Drug Dev Ind Pharm 44(6):982–987. https://doi.org/10.1172/JCI38842
Rice LB (2008) Federal funding for the study of antimicrobial resistance in nosocomial pathogens: no ESKAPE. J Infect Dis 197(8):1079–1081. https://doi.org/10.1086/533452
Sabatier JM (2011) Animal venoms: from deadly arsenals (toxins) to therapeutic drug candidates. Inflamm Allergy Drug Targets 10(5):312. https://doi.org/10.2174/187152811797200632
Schmidt-Lange W (1941) The germicidal effect of bee venom. Muench Med Wochenschr 83:935
Shi W, Li C, Li M, Zong X, Han D, Chen Y (2016) Antimicrobial peptide melittin against Xanthomonas oryzae pv. oryzae, the bacterial leaf blight pathogen in rice. Appl Microbiol Biotechnol 100(11):5059–5067. https://doi.org/10.1007/s00253-016-7400-4
Silva JP, Dhall S, Garcia M, Chan A, Costa C, Gama M, Martins-Green M (2015) Improved burn wound healing by the antimicrobial peptide LLKKK18 released from conjugates with dextrin embedded in a carbopol gel. Acta Biomater 26:249–262. https://doi.org/10.1016/j.actbio.2015.07.043
Smith R, Separovic F, Milne TJ, Whittaker A, Bennett FM, Cornell BA, Makriyannis A (1994) Structure and orientation of the pore-forming peptide, melittin, in lipid bilayers. J Mol Biol 241(3):456–466. https://doi.org/10.1006/jmbi.1994.1520
Socarras KM, Theophilus PAS, Torres JP, Gupta K, Sapi E (2017) Antimicrobial activity of bee venom and melittin against Borrelia burgdorferi. Antibiotics (Basel) 6(4). https://doi.org/10.3390/antibiotics6040031
Soman NR, Baldwin SL, Hu G, Marsh JN, Lanza GM, Heuser JE, Arbeit JM, Wickline SA, Schlesinger PH (2009) Molecularly targeted nanocarriers deliver the cytolytic peptide melittin specifically to tumor cells in mice, reducing tumor growth. J Clin Invest 119(9):2830–2842. https://doi.org/10.1172/JCI38842
Son DJ, Lee JW, Lee YH, Song HS, Lee CK, Hong JT (2007) Therapeutic application of anti-arthritis, pain-releasing, and anti-cancer effects of bee venom and its constituent compounds. Pharmacol Ther 115(2):246–270. https://doi.org/10.1016/j.pharmthera.2007.04.004
Steiner H, Hultmark D, Engström A, Bennich H, Boman HG (1981) Sequence and specificity of two antibacterial proteins involved in insect immunity. Nature 292(5820):246–248. https://doi.org/10.1038/292246a0
Stocker JF (1984) Studies of the action of venom and venom constituents on Escherichia coli. Dissertation, Loughborough University. https://dspace.lboro.ac.uk/2134/25899 (Accessed on December 05, 2018)
Tacón A (2016) Melittin and cancer. J Apither 1(2):51–54. https://doi.org/10.5455/ja.20161027091813
Terwilliger TC, Eisenberg D (1982) The structure of melittin. II. Interpretation of the structure. J Biol Chem 257(11):6016–6022
van den Bogaart G, Guzmán JV, Mika JT, Poolman B (2008) On the mechanism of pore formation by melittin. J Biol Chem 283(49):33854–33857. https://doi.org/10.1074/jbc.M805171200
Varanda EA, Tavares DC (1998) Radioprotection: mechanism and radioprotective agents including honey bee venom. Venom Anim Toxins 4(1):5–21. https://doi.org/10.1590/S0104-79301998000100002
Varanda EA, Monti R, Tavares DC (1999) Inhibitory effect of propolis and bee venom on the mutagenicity of some direct- and indirect-acting mutagens. Teratog Carcinog Mutagen 19(6):403–413. https://doi.org/10.1002/(SICI)1520-6866(1999)19:6<403::AID-TCM4>3.0.CO;2-2
Wade D, Andreu D, Mitchell SA, Silveira AM, Boman A, Boman HG, Merrifield RB (1992) Antibacterial peptides designed as analogs or hybrids of cecropins and melittin. Int J Pept Protein Res 40(5):429–436. https://doi.org/10.1111/j.1399-3011.1992.tb00321.x
Yang L, Harroun TA, Weiss TM, Ding L, Huang HW (2001) Barrel-stave model or toroidal model? A case study on melittin pores. Biophys J 81(3):1475–1485. https://doi.org/10.1016/S0006-3495(01)75802-X
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
This article does not contain any studies with human participants or animals performed by any of the authors.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Memariani, H., Memariani, M., Shahidi-Dadras, M. et al. Melittin: from honeybees to superbugs. Appl Microbiol Biotechnol 103, 3265–3276 (2019). https://doi.org/10.1007/s00253-019-09698-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00253-019-09698-y